Monoamine Transporters
- 1 January 2011
- book chapter
- Published by Elsevier
- Vol. 98, 1-46
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Development Administration (DA016710, DA021409, DA027825)
- Instituto de Salud Carlos III
This publication has 337 references indexed in Scilit:
- Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention‐deficit/hyperactivity disorderAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2010
- Accurate, Large-Scale Genotyping of 5HTTLPR and Flanking Single Nucleotide Polymorphisms in an Association Study of Depression, Anxiety, and Personality MeasuresBiological Psychiatry, 2009
- Monoamine oxidase inactivation: From pathophysiology to therapeuticsAdvanced Drug Delivery Reviews, 2008
- Genome‐wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associationsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Structural determinants of species‐selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studiesProteins: Structure, Function, and Bioinformatics, 2008
- SLC6A4 variation and citalopram responseAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- The synthesis of bivalent 2β-carbomethoxy-3β-(3,4-dichlorophenyl)-8-heterobicyclo[3.2.1]octanes as probes for proximal binding sites on the dopamine and serotonin transportersBioorganic & Medicinal Chemistry, 2008
- Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addictionBiochemical Pharmacology, 2008
- The behavioral pharmacology of hallucinogensBiochemical Pharmacology, 2008
- Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent ratsPsychopharmacology, 2007